Montek (Sodium Molybdate (99mo))

Sodium molybdate, the active ingredient in Montek, is a mineral supplement presented as an injectable solution for intravenous and ocular use. It is employed to address molybdenum deficiency and to support enzymatic processes that require molybdenum as a cofactor.

GNH USA supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Montek (sodium molybdate) is used in clinical settings that involve molybdenum‑dependent metabolic pathways.

- Molybdenum deficiency: restores normal molybdenum levels and supports enzyme activity. - Wilson’s disease adjunct: may aid in copper metabolism modulation when used under specialist supervision. - Diagnostic imaging: employed as a contrast agent in certain hepatic function tests.

Sodium molybdate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild gastrointestinal discomfort. - Headache: transient cranial pain. - Injection site pain: local tenderness or erythema. - Dizziness: temporary light‑headedness. - Transient hypotension: brief drop in blood pressure.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hypersensitivity: rash, swelling, or bronchospasm. - Renal impairment: elevated creatinine or reduced kidney function. - Hepatotoxicity: abnormal liver enzymes. - Hemolysis: destruction of red blood cells.

When using Montek, several precautions should be observed to ensure patient safety and product integrity. - Renal function monitoring: assess serum creatinine before and during therapy. - Hepatic assessment: evaluate liver enzymes in patients with pre‑existing liver disease. - Allergy screening: avoid use in individuals with known hypersensitivity to molybdenum compounds. - Pregnancy consideration: use only if the potential benefit justifies the potential risk to the fetus. - Concomitant copper therapy: monitor copper levels as molybdenum may interfere with copper metabolism. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Sodium molybdate can interact with other substances, influencing its safety and efficacy.

Major Interactions (Avoid): - High‑dose copper supplements: may precipitate copper deficiency and exacerbate toxicity. - Other molybdenum preparations: combined use can lead to molybdenum overload and toxicity.

Moderate Interactions (Monitor Closely): - Drugs metabolized by molybdo‑enzymes (e.g., certain antivirals): potential alteration of drug clearance. - Vitamin B12 therapy: molybdenum may affect B12 absorption. - Anticoagulants: monitor coagulation parameters as molybdenum can influence platelet function.